Top Story

Few infants tested for HCV after birth, more perinatal testing needed

October 24, 2014

PHILADELPHIA — Very few infants in Philadelphia were tested for hepatitis C virus infection after birth despite mothers who reported being positive for the infection, according to data presented at IDWeek 2014. 

“Repetitive and conclusive testing of pregnant women and infants in their first 18 months is necessary to identify vertical transmission of HCV and initiate infected infants into care,” the researchers wrote in the abstract.

Meeting News Coverage

Safety concerns common reason for hepatitis B vaccine refusal

October 24, 2014
SAN DIEGO — Safety and uncertainty involving the risk for hepatitis B are reasons for barriers to vaccine uptake, according to recent study findings presented at…
Meeting News CoverageVideo

New therapies create 'optimistic time' for HCV, expert says

October 24, 2014
PHILADELPHIA — Stanley Martin Cohen, MD, medical director of hepatology at UH Case Medical Center, Cleveland, Ohio, discusses the high points from various…

Potential drug decreased viral load in patients with various HCV genotypes

October 23, 2014
Interim results from an ongoing clinical trial revealed that a microRNA therapeutic was well-tolerated and safe for the treatment of hepatitis C virus infection…
CME
figure

CRITICAL ISSUES IN HBV: Considerations in Optimizing HBV Treatment

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
Meeting News Coverage Video

New therapies create 'optimistic time' for HCV, expert says

October 24, 2014
PHILADELPHIA — Stanley Martin Cohen, MD, medical director of hepatology at UH Case Medical Center, Cleveland…
More »
CME
figure

HCV Consults: Volume 1, Number 1

This activity is supported by educational grants from AbbVie and Genentech.

Physicians seldom experience a paradigm shift in disease management as great as that transpiring in HCV therapy. With…
More »

Filter By:

Meeting News Coverage

Few infants tested for HCV after birth, more perinatal testing needed

October 24, 2014
PHILADELPHIA — Very few infants in Philadelphia were tested for hepatitis C virus infection after birth despite mothers who reported being…
Meeting News Coverage

Safety concerns common reason for hepatitis B vaccine refusal

October 24, 2014
SAN DIEGO — Safety and uncertainty involving the risk for hepatitis B are reasons for barriers to vaccine uptake, according to recent study…
Meeting News Coverage Video

New therapies create 'optimistic time' for HCV, expert says

October 24, 2014
PHILADELPHIA — Stanley Martin Cohen, MD, medical director of hepatology at UH Case Medical Center, Cleveland, Ohio, discusses the high points…

Potential drug decreased viral load in patients with various HCV genotypes

October 23, 2014
Interim results from an ongoing clinical trial revealed that a microRNA therapeutic was well-tolerated and safe for the treatment of hepatitis C…
figure Meeting News Coverage

Decreased hemoglobin levels did not impact SVR rate in patients treated for HCV genotype 1

October 22, 2014
PHILADELPHIA — Decreased hemoglobin levels were well-managed in patients with hepatitis C virus infection receiving a three direct-acting…

HCV nucleotide analogue polymerase inhibitor associated with cardiac dysfunction

October 20, 2014
Fourteen of 34 patients with hepatitis C virus infection who were treated with the novel nucleotide analogue polymerase inhibitor BMS-986094 had some…
In the Journals

SVR after therapy reduced inflammation, fibrosis in HCV patients

October 17, 2014
In a new study, patients with chronic hepatitis C virus infection who achieved a sustained virologic response with interferon-based therapy…
In the Journals

Polymorphisms increased risk for steatosis in patients with HCV genotype 1

October 15, 2014
Phospholipase domain containing 3, or PNPLA3, polymorphism was a predictor for steatosis among Spanish patients with hepatitis C virus genotype 1…
FDA News Perspective

FDA approves Harvoni for HCV treatment

October 10, 2014
Using the breakthrough therapy designation, the FDA approved the first combination pill for treatment of chronic hepatitis C virus genotype 1 that…
figure In the Journals

Spontaneous HBeAg seroclearance increased chances for HBsAg seroclearance

October 8, 2014
Patients with chronic hepatitis B virus infection and positive for the hepatitis B e antigen had a greater chance of hepatitis B surface antigen…
More Headlines »